Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Anticancer Research|December 30, 2023
Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative TreatmentToru Aoyama, Aya Kato, Yukio Maezawa, et al.
Anticancer Research|December 30, 2023
Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative TreatmentAya Kato, Toru Aoyama, Yukio Maezawa, et al.
Anticancer Research|July 27, 2022
The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative TreatmentMiwha Ju, Toru Aoyama, Keisuke Komori, et al.
International Journal of Clinical Oncology|April 12, 2024
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical OncologySeiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, et al.
Annals of Surgical Oncology|September 17, 2014
Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literatureHaruhiko Cho, Junichi Nakamura, Yoshihide Asaumi, et al.
Anticancer Research|August 30, 2022
Clinical Impact of Surgical Sarcopenia on Long-term SurvivalKeisuke Komori, Kazuki Kano, Toru Aoyama, et al.
Annals of Surgical Oncology|May 20, 2020
Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric CancerKazuki Kano, Takanobu Yamada, Kouji Yamamoto, et al.
In Vivo (Athens, Greece)|August 31, 2023
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal CancerHiroshi Tamagawa, Ayako Tamagawa, Toru Aoyama, et al.
Anticancer Research|March 6, 2020
Impact of Postoperative Complications on Recurrence in Patients With Stage II/III Gastric Cancer Who Received Adjuvant Chemotherapy With S-1Hayato Watanabe, Tsutomu Hayashi, Keisuke Komori, et al.
In Vivo (Athens, Greece)|February 28, 2024
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative TreatmentMomoko Fukuda, Toru Aoyama, Itaru Hashimoto, et al.
Pageof 22